Columvi

glofitamab-gxbm

Approval

ApplicationBLA 761309
Approval dateJun 15, 2023
Approval year2023
SponsorGenentech INC

FDA-approved use

To treat diffuse large B-cell lymphoma, not otherwise specified, or large B-cell lymphoma arising from follicular lymphoma after two or more lines of systemic therapy

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Columvi: